The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Newest first

New topics page 14

Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.

1,535 topics · page 14 of 40

TopicParticipantsRepliesViewsActivity
Follow-up: How to disagree with an answer you were given, well
How to disagree with an answer you were given, well I have a specific reason for asking rather than idle curiosity, and the context is below. Question in the title and the context underneath, in the order the…
RMCCHO 2 16k 30d
CJC-1295 with and without DAC: what the modification does
On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
MSNCDHEHNE+117 123 5.6k 22h
Follow-up: Patterns that reliably precede a problem, documented
On the subject in the title: Patterns that reliably precede a problem, documented Working notes rather than a conclusion. A follow-up question about Patterns that I did not know to ask the first time. The…
AKENRL 2 70 1d
Preservatives: function, testing, and limits — one year on
On the subject in the title: Preservatives: function, testing, and limits — one year on Working notes rather than a conclusion. Asking about Preservatives directly, because I have read four threads on it and…
SDKBBHKHA+28 32 437 8d
A widely repeated interaction claim that turns out to be unsupported — what changed since
A widely repeated interaction claim that turns out to be unsupported — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about widely repeated…
GVANGAKAK+89 94 5.9k 2h
Coming back to: Light exposure: how much protection is proportionate?
Asking directly, because I could not find a straight answer: Light exposure: how much protection is proportionate? Reading back through what has been written here about Light exposure, three questions come up…
MBJWHADHSM+5 10 13k 2d
Preprint servers and what screening they do — the long version
On the subject in the title: Preprint servers and what screening they do — the long version Working notes rather than a conclusion. A preprint question rather than a question about the finding in it. The…
APNEYASSRM+7 11 26k 4mo
When a dose reduction is the correct response to a side effect
When a dose reduction is the correct response to a side effect — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have…
VMSRMJSTD+38 42 2.7k 19h
Revisiting: Maintainer handover: how it works
Revisiting: Maintainer handover: how it works Writing it up because I had to work it out twice and would rather nobody else did. Maintainer handover keeps being re-asked here and I think that is because the…
SCNITPESUC+53 57 664 4mo
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
WVERFYWMB+124 133 11k 5mo
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
HVMRSC 2 182 21h
[2026 update] Regional warehouse stock versus direct despatch
Regional warehouse stock versus direct despatch Writing it up because I had to work it out twice and would rather nobody else did. Working notes on Regional warehouse stock versus direct rather than a…
RSBEERBSRM+135 147 32k 2d
What other technical communities get right that we do not
What other technical communities get right that we do not — that is the question, and I have not found it answered plainly anywhere I have looked. A digression I have been saving for the right category. It is…
GRBBMTLJD+2 6 23k 5h
Why this subcategory is stricter about sourcing than most
Asking directly, because I could not find a straight answer: Why this subcategory is stricter about sourcing than most A comparison question rather than a question about one compound. Two things in the same…
DOCAEFRESC+48 52 617 21d
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on
Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Posting the method first, because I know what the first three…
MSFKJBMRCR+10 14 13k 5mo
The headache that turns out to be dehydration — the long version
On the subject in the title: The headache that turns out to be dehydration — the long version Working notes rather than a conclusion. A narrow question about headache, deliberately narrow, because the broad…
NDMPBFAARZ+68 73 1.3k 12h
About the Special populations category
Older adults, pregnancy and pregnancy planning, adolescents, renal and hepatic impairment, bariatric surgery history. This post is a community wiki: any member at trust level 3 or above can edit it, and every…
SLOBMAFPJS 4 3k 4mo
Resolution and tailing factor: real acceptance criteria
Resolution and tailing factor: real acceptance criteria Writing it up because I had to work it out twice and would rather nobody else did. Asking about resolution and tailing factor on behalf of the question…
NLPNV 2 15k 1mo
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
KBLKSSJLB+120 132 13k 1d
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
MSPMAICLAP+104 110 16k 2d
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Writing this out with the numbers in it, because…
EBJTGCHNS+8 12 4.3k 1d
About the Doc review category
Review of drafts and revisions before and after promotion. Every promotion is discussed in public. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
HSTVDSNKMA 4 25k 4mo
Mass error in ppm: the arithmetic and the caveat
Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
KCCIAMCDBV+108 125 1.5k 5mo
[2026 update] Composite endpoints and the component doing the work
On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet , 2021) and…
CRSFDVFJP+76 87 994 3mo
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold?
Asking directly, because I could not find a straight answer: What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still hold? An honest uncertainty about TRIUMPH rather than a…
DNSLITNCAS+43 47 5.5k just now
Nausea profile of amylin analogues compared with GLP-1 agonists
Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin nausea profile of…
CRIGELZAG+70 76 3k 4mo
Second pass at: Identical chromatograms across two different lots
Posting this under the heading it deserves: Second pass at: Identical chromatograms across two different lots Everything below is what sits behind that. Something about Identical chromatograms does not…
QZAWTSKAAD+81 93 13k 4mo
About the HPLC & UHPLC category
Reversed-phase separations, gradients, columns, integration, and reading a chromatogram properly. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
KBNKBNCPB 4 137 18h
Type 2 diabetes and the largest part of the evidence base
Posting this under the heading it deserves: Type 2 diabetes and the largest part of the evidence base Everything below is what sits behind that. Trying to work out what would count as evidence on type 2…
CNFNAISCJB+81 89 2.9k 3mo
A genuinely late dose: what the labelling says and what people do
On the subject in the title: A genuinely late dose: what the labelling says and what people do Working notes rather than a conclusion. A methods question rather than a substantive one, about genuinely late…
EVJFST 2 18k 5mo